Align Technology, Inc.
NASDAQ:ALGNMedical - Devices
-$5.99 today
- Market cap
- $11.56B
- Beta
- 1.67
- P/E (TTM)
- 28.8
- EPS (TTM)
- $6.02
Volume 0.89M
Average 1.05M
ALGN Common Stock Issued
Cash raised by issuing new shares.
Align Technology, Inc.NASDAQ: ALGN
Common Stock Issued · Q2 FY2026 · quarter ended Jun 2026
Common stock issued turns negative
Q2 FY2026 common stock issued was -$11.72M, compared with $0 a year earlier. Trailing-twelve-month common stock issued was $7.84M. Over 3 fiscal years it compounded at -6.0% a year.
Context
- Common stock issued amounted to 0.5% of revenue in FY2025, unchanged from a year earlier.
- Common stock issued increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly common stock issued holds near -$11.72M or moves back toward the trailing-twelve-month quarterly average of $1.96M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 21.75M USD
- Year-over-year change
- -14.0%
- 4-year CAGR
- -4.0%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.75M | -14.0% |
| FY2024 | 2024-12-31 | 25.28M | -4.9% |
| FY2023 | 2023-12-31 | 26.6M | +1.7% |
| FY2022 | 2022-12-31 | 26.15M | +2.1% |
| FY2021 | 2021-12-31 | 25.62M | — |
Common Stock Issued vs competitors
How ALGN compares with its peers on the latest reported figures
- ALGN's LTM Jun 2026 common stock issued of $7.84M is the largest of the 3 companies compared; the peer median is $550K.
- Its year-over-year change of -68.5% is the lowest of 2, against a peer median of -62.1%.
- Common stock issued amounts to 0.2% of revenue for ALGN, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $7.84M | -68.5% | -6.0% | 0.2% | |
| LTM Oct 2026 | $1.1M | -62.1% | -49.5% | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ALGN) | $550K | -62.1% | -49.5% | 0.0% | |
Competitors are the stored peer set for ALGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 772.02M | 361.57M | 445.05M | 421.36M | 410.35M |
| Depreciation & Amortization | 108.73M | 125.79M | 142.4M | 145.03M | 237.44M |
| Deferred Income Tax | 15.46M | (39.5M) | (18.64M) | 25.76M | 33.09M |
| Stock-Based Compensation | 114.34M | 133.37M | 154.03M | 173.7M | 185.87M |
| Change in Working Capital | 154.24M | (84.31M) | (7.89M) | (72.43M) | (356.02M) |
| Accounts Receivables | (262.07M) | 21.55M | (104.61M) | (153.49M) | (139.91M) |
| Inventory | (112.45M) | (130.1M) | 30.17M | 25.05M | 808K |
| Accounts Payables | 19.75M | (36.52M) | (7.7M) | (843K) | 5.33M |
| Other Working Capital | 509.01M | 60.76M | 74.26M | 56.84M | (222.24M) |
| Other Non-Cash Items | 7.77M | 71.81M | 70.83M | 44.81M | 82.5M |
| Operating Cash Flow | 1.17B | 568.73M | 785.78M | 738.23M | 593.22M |
| Capital Expenditures | (401.1M) | (291.9M) | (177.72M) | (115.58M) | (102.45M) |
| Acquisitions (Net) | (8M) | (12.3M) | (77M) | (183.42M) | 0 |
| Purchases of Investments | (200.93M) | (28M) | (2.91M) | 0 | (10M) |
| Sales of Investments | 47.02M | 121.1M | 61.4M | 43.85M | 0 |
| Other Investing Activities | (417K) | (2.21M) | 278K | 235K | 0 |
| Investing Cash Flow | (563.43M) | (213.32M) | (195.94M) | (254.91M) | (112.45M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 25.62M | 26.15M | 26.6M | 25.28M | 21.75M |
| Common Stock Repurchased | (375.04M) | (435.04M) | (592.36M) | (352.88M) | (465.94M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (108.92M) | (92.8M) | (32.58M) | (28.13M) | (20.39M) |
| Financing Cash Flow | (458.33M) | (501.69M) | (598.34M) | (355.72M) | (464.58M) |
| Effect of Forex Changes | (12.12M) | (11.51M) | 4.67M | (21.15M) | 35.03M |
| Net Change in Cash | 138.67M | (157.78M) | (3.84M) | 106.44M | 51.22M |
| Free Cash Flow | 771.45M | 276.83M | 608.06M | 622.65M | 490.78M |
Align Technology, Inc.
NASDAQ:ALGN
Intrinsic Alpha fair value
Locked
Current Price
$163.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.